Organogenesis Holdings Inc. to Present at the BTIG Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools Conference

Organogenesis Holdings Inc. to Participate in BTIG Snowbird MedTech Conference.

On February 13th and 14th, Organogenesis Holdings Inc. (Nasdaq: ORGO) will participate in the BTIG Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools Conference, to be held at the Cliff Lodge in Snowbird, UT. Management will attend the event for no formal presentation but will participate in 1×1 meetings on February 14th.

Organogenesis Holdings Inc. is a leading regenerative medicine company that focuses on developing, manufacturing, and commercializing product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets. The company offers a comprehensive portfolio of innovative regenerative products aimed at addressing patient needs across the continuum of care. For more information about Organogenesis Holdings Inc., visit www.organogenesis.com.

Investors can direct their inquiries to ICR Westwicke through Mike Piccinino, CFA at OrganoIR@westwicke.com. Press and media inquiries can be directed to Organogenesis at communications@organo.com

Leave a Reply

Pakistan’s new government faces nearly impossible tasks with over 30 percent inflation Previous post Pakistan’s Elections Amid Economic and Geopolitical Challenges: Can the New Government Rise to the Occasion?
US Secretary of Defense Lloyd Austin hospitalized in intensive care for another health issue Next post Secretary of Defense Lloyd Austin’s Health Struggles Raise Concerns Over Department Leadership Succession